Regulator

EMA

Monitor European Medicines Agency pharmacovigilance and regulatory intelligence: PRAC signal assessments, EudraVigilance monitoring expectations under EU GVP, product information updates, and centrally authorised product safety actions. Each briefing maps EMA developments to workflows such as signal validation, label governance, and QPPV oversight.

1 update · Sorted by impact priority

publicEma · Updated May 21, 2026

MaaT Pharma flags CHMP “negative trend” ahead of June vote

Urgency: Medium

Ema update requires triage for Label Governance, Risk Management, AI / GxP Governance; confirm local obligations and document follow-up actions.

Label GovernanceRisk ManagementSignal Management Lead

SOP Impact5 SOPs

ConfidenceMedium

Relevant for: Signal Management Lead, Labeling Lead, Regulatory Intelligence Lead

verifiedRegulatory action: Latest

Read impact briefarrow_forward

Get updates for your PV role

Subscribe to impact-first pharmacovigilance updates. Select every role you want in your digest.

Digest roles: QPPV. Work email only